Mujeeb U. Shad, MD, MSCS

  • 10Articles
  • 68.9KReads
  • 1997–2024Active
  • 22Collaborators
  • 44Citations

About

Mujeeb U. Shad, MD, MSCS is affiliated with University of Nevada, Las Vegas, Nevada. Mujeeb U. Shad has authored or co-authored 10 peer-reviewed articles published across the Journal of Clinical Psychiatry and the Primary Care Companion for CNS Disorders between 1997 and 2024. Their work focuses on Depression (MDD), Schizophrenia/Schizoaffective Disorders, Posttraumatic Stress Disorder, Psychedelics, and Psychiatry.

Publications

PCC
Evolution of Treatment Modalities for PTSD
Original Research

Evolution of Treatment Modalities for PTSD

December 12, 2024

The authors provide a bibliometric analysis of the most-cited articles published from 1990 to 2020 on evidence-based treatment modalities for PTSD to highlight significant developments in its understanding and management.
, , , et al
PCC
NIH Funding Trends in Psychiatry by Gender
Brief Report

NIH Funding Trends in Psychiatry by Gender

September 19, 2024

The authors examined NIH funding patterns in the distribution of R01 grants for gender-specific psychiatry research.
, , , et al
PCC
Neurobiological Correlates of Psilocybin Response in MDD
Systematic Review

Neurobiological Correlates of Psilocybin Response in MDD

May 23, 2023

Transient functional brain changes with psilocybin therapy resemble the “brain reset” phenomenon and may serve as the putative predictors of psilocybin antidepressant response.
, , , et al
PCC
High-Dose Therapy in Treatment-Refractory Psychosis
Original Research

High-Dose Therapy in Treatment-Refractory Psychosis

November 24, 2022

In forensic patients hospitalized in a long-term psychiatric facility, antipsychotic dose reduction had a positive effect on treatment effectiveness, competency restoration, and hospital discharge with no symptom relapse.
PCC
TMS for Schizophrenia Management
Systematic Review

TMS for Schizophrenia Management

August 25, 2022

In this review, the authors analyze all current literature related to different transcranial magnetic stimulation modalities in the management of schizophrenia symptoms.
, ,
PCC
Case Report

Acute Aggression After Progesterone Discontinuation

January 27, 2022

This report describes a case of acute aggression in a young woman after the discontinuation of a subdermal etonogestrel implant and resolution of aggression after the initiation of DMPA...
PCC
Brief Report

Clozapine Levels and Inflammatory Stress

July 2, 2020

Stress-induced changes in pharmacokinetics can alter plasma levels of drugs like clozapine. This brief report describes the case of a man with schizoaffective disorder who showed sustained elevation in...
,
PCC
Brief Report

Aripiprazole for Management of Antipsychotic-Induced Hyperprolactinemia

January 30, 2020

Hyperprolactinemia is often observed in patients treated with antipsychotic medications. Low-dose treatment with aripiprazole may offer a relatively rapid relief from sustained hyperprolactinemia and associated adverse effects.
,
PCC
Article

Glabellar Botulinum for Depression

October 4, 2018

Glabellar injection of botulinum toxin A (BTA) provides a novel and interesting strategy to address shortcomings in the treatment of depression. This study examines the primary clinical trials conducted...
, ,
JCP
Letter to the Editor

A Possible Pharmacokinetic Interaction Between Fluoxetine and Acetylsalicylic Acid

December 15, 1997

, ,

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe